DEF 14AThe Ballot
Intellia Therapeutics, Inc. files DEF 14A
Filed May 2, 2022 · 4y ago · Accession 0000950170-22-006882
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Intellia Therapeutics, Inc.
- Ticker
- NTLA
- CIK
- 1652130
- Form type
- DEF 14A
- Filing date
- May 2, 2022
- Report date
- Jun 14, 2022
- Document
- ntla_def_14a_2022.htm
- Size
- 1.9 MB